These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8555467)

  • 1. Distinctive expression pattern of the BCL-6 protein in nodular lymphocyte predominance Hodgkin's disease.
    Falini B; Bigerna B; Pasqualucci L; Fizzotti M; Martelli MF; Pileri S; Pinto A; Carbone A; Venturi S; Pacini R; Cattoretti G; Pescarmona E; Lo Coco F; Pelicci PG; Anagnastopoulos I; Dalla-Favera R; Flenghi L
    Blood; 1996 Jan; 87(2):465-71. PubMed ID: 8555467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bcl-6 protein expression in normal and neoplastic lymphoid tissues.
    Falini B; Fizzotti M; Pileri S; Liso A; Pasqualucci L; Flenghi L
    Ann Oncol; 1997; 8 Suppl 2():101-4. PubMed ID: 9209651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression status of BCL-6 and syndecan-1 identifies distinct histogenetic subtypes of Hodgkin's disease.
    Carbone A; Gloghini A; Gaidano G; Franceschi S; Capello D; Drexler HG; Falini B; Dalla-Favera R
    Blood; 1998 Oct; 92(7):2220-8. PubMed ID: 9746758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus-associated Hodgkin's disease derives from post-germinal center B cells.
    Carbone A; Gloghini A; Larocca LM; Antinori A; Falini B; Tirelli U; Dalla-Favera R; Gaidano G
    Blood; 1999 Apr; 93(7):2319-26. PubMed ID: 10090942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies PG-B6a and PG-B6p recognize, respectively, a highly conserved and a formol-resistant epitope on the human BCL-6 protein amino-terminal region.
    Flenghi L; Bigerna B; Fizzotti M; Venturi S; Pasqualucci L; Pileri S; Ye BH; Gambacorta M; Pacini R; Baroni CD; Pescarmona E; Anagnostopoulos I; Stein H; Asdrubali G; Martelli MF; Pelicci PG; Dalla-Favera R; Falini B
    Am J Pathol; 1996 May; 148(5):1543-55. PubMed ID: 8623923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A specific monoclonal antibody (PG-B6) detects expression of the BCL-6 protein in germinal center B cells.
    Flenghi L; Ye BH; Fizzotti M; Bigerna B; Cattoretti G; Venturi S; Pacini R; Pileri S; Lo Coco F; Pescarmona E
    Am J Pathol; 1995 Aug; 147(2):405-11. PubMed ID: 7639334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell/histiocyte-rich large B-cell lymphoma: a heterogeneous entity with derivation from germinal center B cells.
    Lim MS; Beaty M; Sorbara L; Cheng RZ; Pittaluga S; Raffeld M; Jaffe ES
    Am J Surg Pathol; 2002 Nov; 26(11):1458-66. PubMed ID: 12409722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCL-6 protein is expressed in germinal-center B cells.
    Cattoretti G; Chang CC; Cechova K; Zhang J; Ye BH; Falini B; Louie DC; Offit K; Chaganti RS; Dalla-Favera R
    Blood; 1995 Jul; 86(1):45-53. PubMed ID: 7795255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BCL-6 gene product, a 92- to 98-kD nuclear phosphoprotein, is highly expressed in germinal center B cells and their neoplastic counterparts.
    Onizuka T; Moriyama M; Yamochi T; Kuroda T; Kazama A; Kanazawa N; Sato K; Kato T; Ota H; Mori S
    Blood; 1995 Jul; 86(1):28-37. PubMed ID: 7795234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reed-Sternberg cells of classical Hodgkin's disease react with the plasma cell-specific monoclonal antibody B-B4 and express human syndecan-1.
    Carbone A; Gloghini A; Gattei V; Degan M; Improta S; Aldinucci D; Canzonieri V; Perin T; Volpe R; Gaidano G; Zagonel V; Pinto A
    Blood; 1997 May; 89(10):3787-94. PubMed ID: 9160685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcription factor B-cell-specific activator protein (BSAP) is differentially expressed in B cells and in subsets of B-cell lymphomas.
    Krenacs L; Himmelmann AW; Quintanilla-Martinez L; Fest T; Riva A; Wellmann A; Bagdi E; Kehrl JH; Jaffe ES; Raffeld M
    Blood; 1998 Aug; 92(4):1308-16. PubMed ID: 9694719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BCL-6 expression during B-cell activation.
    Allman D; Jain A; Dent A; Maile RR; Selvaggi T; Kehry MR; Staudt LM
    Blood; 1996 Jun; 87(12):5257-68. PubMed ID: 8652841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-level nuclear NF-kappa B and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells.
    Bargou RC; Leng C; Krappmann D; Emmerich F; Mapara MY; Bommert K; Royer HD; Scheidereit C; Dörken B
    Blood; 1996 May; 87(10):4340-7. PubMed ID: 8639794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiapoptotic marker Bcl-X(L), expression on Reed-Sternberg cells of Hodgkin's disease using a novel monoclonal marker, YTH-2H12.
    Chu WS; Aguilera NS; Wei MQ; Abbondanzo SL
    Hum Pathol; 1999 Sep; 30(9):1065-70. PubMed ID: 10492041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can Reed-Sternberg cells of classic Hodgkin's disease be considered B-cells?
    Carbone A; Gloghini A; Gaidano G
    Adv Clin Path; 1999; 3(1-2):3-9. PubMed ID: 10655568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus and bcl-2 protein overexpression are not detected in the neoplastic cells of nodular lymphocyte predominance Hodgkin's disease.
    Alkan S; Ross CW; Hanson CA; Schnitzer B
    Mod Pathol; 1995 Jun; 8(5):544-7. PubMed ID: 7675775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD40 Ligand--an anti-apoptotic molecule in Hodgkin's disease.
    Metkar SS; Manna PP; Anand M; Naresh KN; Advani SH; Nadkarni JJ
    Cancer Biother Radiopharm; 2001 Feb; 16(1):85-92. PubMed ID: 11279801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nodular lymphocyte-predominant Hodgkin's disease associated with large-cell lymphoma: analysis of Ig gene rearrangements by V-J polymerase chain reaction.
    Greiner TC; Gascoyne RD; Anderson ME; Kingma DW; Adomat SA; Said J; Jaffe ES
    Blood; 1996 Jul; 88(2):657-66. PubMed ID: 8695813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease.
    Carbone A; Gloghini A; Gruss HJ; Pinto A
    Am J Pathol; 1995 Oct; 147(4):912-22. PubMed ID: 7573367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression pattern of MUM1/IRF4 in the spectrum of pathology of Hodgkin's disease.
    Carbone A; Gloghini A; Aldinucci D; Gattei V; Dalla-Favera R; Gaidano G
    Br J Haematol; 2002 May; 117(2):366-72. PubMed ID: 11972519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.